Through its partnership with the Abramson Cancer Center, the Penn Brain Tumor Center offers access to innovative advances in treatment -- including immunotherapy -- through personalized clinical trials.
The twofold object of these trials is to extend patient survival beyond its current average, and to generate a database of critical information for neurosurgeons and oncologists worldwide.
Among other accomplishments, the Penn Brain Tumor Center has the leading CAR-T for glioblastoma clinical research program in the nation.
Providers, if you think your patient may be a candidate for neurosurgery at Penn Medicine, consult on our provider-only line: 877-937-PENN (7366)
Related links:
Weekly Tumor Board Meetings at the Penn Brain Tumor Center
The Brain Tumor Center | Improving Outcomes for Brain Tumor Patients
Brain Tumor Center
Glioblastoma Immunotherapy Research at Penn Medicine, Including CART-EGFRvIII Therapy
Follow clinical updates from Penn on Twitter
Related Videos
